What is Locate Bio?
Locate Bio operates at the intersection of advanced material science and clinical orthopedics. The company specializes in the development of sophisticated drug delivery systems and tissue scaffolds designed to facilitate the repair and regeneration of musculoskeletal tissues. By focusing on high-impact therapeutic areas, Locate Bio aims to replace traditional, less effective surgical interventions with bio-active solutions that promote natural healing processes. Their market position is defined by a commitment to rigorous scientific validation and the pursuit of scalable, next-generation medical devices that address the growing global demand for orthopedic innovation.
How much funding has Locate Bio raised?
Locate Bio has raised a total of $27.3M across 3 funding rounds:
Unspecified
$2.8M
Private Equity
$13.8M
Other Financing Round
$10.7M
Unspecified (2020): $2.8M with participation from Mercia Asset Management
Private Equity (2021): $13.8M led by Mercia Asset Management and BGF
Other Financing Round (2024): $10.7M supported by Mercia Technologies
Key Investors in Locate Bio
Mercia Asset Management
Mercia Asset Management provides equity and debt financing to UK businesses with growth ambitions, acting as investment partners from scale-up to exit. They offer venture capital, business loans, and private equity to accelerate growth and impact.
BGF
BGF is the most active and influential investor in small and mid-sized businesses in the UK, supporting a range of growing companies across every region and sector of the economy.
What's next for Locate Bio?
Looking ahead, the strategic deployment of the $10.7M will likely focus on scaling manufacturing capabilities and advancing clinical trial programs. As the company moves deeper into its growth phase, the emphasis will shift toward regulatory milestones and commercialization strategies. The continued support from institutional backers suggests a long-term commitment to building a sustainable, high-growth enterprise capable of disrupting the musculoskeletal market. Future efforts will likely prioritize the expansion of their intellectual property portfolio and the establishment of strategic partnerships to facilitate broader market access for their innovative therapeutic platforms.
See full Locate Bio company page
